Lucid Diagnostics Inc (LUCD) Stock Price, Quote & News

Company Profile

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths th...

Industry: Medical Devices

Sector: Healthcare

Phone: 917 813 1828

Website: www.luciddx.com

Address:

360 Madison Avenue, 25th Floor, New York, United States

SuperGreenToday Dec. 23 at 3:21 AM

$LUCD

0 · Reply

Ironbow Dec. 21 at 2:58 PM

$LUCD Dave and his three personalities are sick !!

0 · Reply

LPlates Dec. 21 at 4:34 AM

$LUCD I said before Abbott bought Exact Sciences that they were the only true buyer at between $400M and $500M. So with 230 million shares outstanding between $1.75 and $2.20. As soon as the deal was announced I said EXAS will do nothing until the deal is closed and that LUCD will trade at around 50 cents in 2026. That's called adjusting your views based on changing scenarios or information. Just like you should change your because there is NO DRAFT LCD until after the peer review process has completed. Best BEST case it's Summer 2026, more likely case Q4 2026 or 2027. You have been given new information why don't you try and prove it wrong? If you do (you won't) then all the PUMPERS on Stock twits will call you the greatest. But when you don't then you have the opportunity to save over $1 million dollars. Surely that is motivation enough. You can not point to a single instance I have been wrong yet you refuse to try and tear apart the information I have given you!! NUTS

0 · Reply

Carter113 Dec. 21 at 12:25 AM

$LUCD Merry Christmas Dave!! I hope in the new year you get a new life!! The amount of time you spend here bashing is so F’ing funny!! We are on like 8 dooms day scenarios from you now, and we are still standing!!!! Most all of us alherr like me are long and strong!!! Your still a 🤡🤡🤡 Seven figures long waiting, see you on the other side!!! 🫏💩

2 · Reply

dmc4321 Dec. 20 at 7:50 PM

$LUCD [Unverified] The fact that the 12,000-patient study is currently a pre-print and not yet peer-reviewed is a critical administrative pivot. In the world of Medicare policy, this status changes the study from a "primary driver" of coverage to a "procedural anchor" for delay.1. The "GRADE" Evidence PenaltyMolDX uses the GRADE framework to evaluate the quality of evidence. Under this system:Peer-Reviewed Literature: Can be graded as "Moderate" or "High" certainty depending on design.Pre-prints: Are almost universally downgraded to "Very Low Certainty." [Inference] MolDX policy typically prohibits expanding coverage based on "Very Low Certainty" evidence. Therefore, while the MAC (Palmetto GBA) is now aware of the data, they cannot legally use it as the scientific basis for a positive coverage determination until the final Version of Record (VoR) is published in a recognized journal.2.

1 · Reply

quegoalasoche Dec. 20 at 11:14 AM

$PAVM $LUCD

0 · Reply

LPlates Dec. 20 at 6:12 AM

$LUCD I feel hurt 🤕🤕🤕. Unloved. Al I did 😁 was repost @oaksapollo post that shows WITHOUT a CAC it's a 9 MONTH wait till MolDX publishes a draft. And @Lets_Go_Brndn Grok analysis that said a realistic time frame was MORE than 9 months. It was their posts that said LUCD's next Catalyst was SUMMER 🌞🌞🌞⛱️⛱️⛱️ of 2026. Not me. THEM. Okay I felt obliged to say that getting FULL CMS approval by May of 2026 was a CRITICAL COVENANT of the Convertible but @oaksapollo was the first one to post that FACT. 😁 It's not as if I'm posting IMMINENT every day. I'm excited about the next count down calender. Is there a limit of two wrong ones in a year or can we start a 3rd? What would be real interesting and educational I think is to check everyone's predictions and see who was accurate. Don't you feel there would be real value in that. We could award 🐂 shitter 1st class, 2nd class etc. and For the person who was right maybe a God like image with a halo 😇 spelling out DAVE!

0 · Reply

Researchpro Dec. 19 at 9:43 PM

$LUCD its pretty heavy volume AH too but not much movement. Any clue what is happening? Past fee days volume has increased slightly but this is 2.7 million traded today at close it was 2.24 million. That is our avg daily volume happening after close so far

1 · Reply

Investbythenumbers Dec. 19 at 9:38 PM

$LUCD Make no mistake about it, once the draft LCD is issued this board will go 100% Bullish and the resident knuckle head DMC will disappear into oblivion! Anyone doing tax loss selling will be very upset IMO!

1 · Reply

Researchpro Dec. 19 at 9:31 PM

$LUCD anticipation is building up, heavy volume today but also heavy sell volume to close

0 · Reply

Market Cap	155.58M
Revenue (ttm)	4.35M
Net Income (ttm)	-45.53M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,046.67%
Debt to Equity Ratio	0.86

Volume	304,100
Avg Vol	718,118
Day's Range	N/A - N/A
Shares Out	137.68M
Stochastic %K	13%
Beta	1.23
Analysts	Strong Sell
Price Target	$3.79